CMBA
APYX icon

C.M. Bidwell & Associates’s Apyx Medical APYX Stock Holding History

C.M. Bidwell & Associates’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,610
Closed -$17K – 396
2018
Q4 		$17K Buy
+2,610
New +$15.8K 0.02% 298

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

C.M. Bidwell & Associates's APYX Position: Q1 2019 in Review

C.M. Bidwell & Associates sold out of Apyx Medical (APYX) in Q1 2019, closing a stake of 2,610 shares — an estimated $17K sold.

C.M. Bidwell & Associates first reported a position in APYX in Q4 2018 and held it in 1 quarter. The position peaked at $17K in Q4 2018. 78 funds tracked by Wall St. Rank hold APYX as of Q1 2019.

  • C.M. Bidwell & Associates reported no remaining Apyx Medical position as of Q1 2019 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 2,610 Apyx Medical shares in Q1 2019, an estimated $17K.
  • C.M. Bidwell & Associates first reported a position in Apyx Medical in Q4 2018 and held it in 1 quarter.
  • C.M. Bidwell & Associates's Apyx Medical position peaked at $17K in Q4 2018.
  • 78 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2019.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2019, filed 15 May 2019.